Time course of changes in pyridoxal 5′-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage

Experimental Neurology

Volumn 206, Issue 1, 2007, Pages 114-125

  Hwang, In Koo ^a   Yoo, Ki Yeon ^a   Kim, Do Hoon ^a   Lee, Bong Hee ^b   Kwon, Young Guen ^c   Won, Moo Ho ^a  

^a Hallym University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

GABA; Glutamic acid decarboxylase; Ischemic damage; Neuroprotection; Pyridoxal 5 phosphate; Vitamin B6

Indexed keywords

GLUTAMATE DECARBOXYLASE; OXIDOREDUCTASE; PHOSPHATASE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL 5 PHOSPHATE OXIDASE; PYRIDOXAL PHOSPHATE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; GERBIL; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TRANSIENT ISCHEMIC ATTACK;

4-AMINOBUTYRATE TRANSAMINASE; ALDEHYDE OXIDOREDUCTASES; ANIMALS; ASTROCYTES; BRAIN INFARCTION; BRAIN ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME ACTIVATION; GAMMA-AMINOBUTYRIC ACID; GERBILLINAE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; NEURAL INHIBITION; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORIC MONOESTER HYDROLASES; PYRAMIDAL CELLS; PYRIDOXAL PHOSPHATE; TIME FACTORS; UP-REGULATION;

EID: 34250690463     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.04.005     Document Type: Article

References (54)

1. 6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor. J. Biol. Chem. 268 (1993) 20870-20876
2. Arvin K.L., Han B.H., Du Y., Lin S.Z., Paul S.M., and Oltzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52 (2002) 54-61
3. Babcock A.M., Everingham A., Paden C.M., and Kimura M. Baclofen is neuroprotective and prevents loss of calcium/calmodulin-dependent protein kinase II immunoreactivity in the ischemic gerbil hippocampus. J. Neurosci. Res. 67 (2002) 804-811
4. Bahn J.H., Kwon O.S., Joo H.M., Jang S.H., Park J., Hwang I.K., Kang T.C., Won M.H., Kwon H.Y., Kwok F., Kim H.B., Cho S.W., and Choi S.Y. Immunohistochemical studies of brain pyridoxine-5′-phosphate oxidase. Brain Res. 925 (2002) 159-168
5. Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim. Biophys. Acta 1647 (2003) 36-41
6. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., and Tobin A.J. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2115-2119
7. A-mediated inhibitory postsynaptic potentials in the CA1 region of hippocampus. Neuropsychopharmacology 27 (2002) 960-969
8. Chen C.-H., Battahlioli G., Martin D.L., Hobart S.A., and Colon W. Distinctive interactions in the holoenzyme formation for two isoforms of glutamate decarboxylase. Biochim. Biophys. Acta 1645 (2003) 63-71
9. Choi J.D., Bowers-Komro M., Davis M.D., Edmondson S.E., and McCormick D.B. Kinetic properties of pyridoxamine (pyridoxine)-5′-phosphate oxidase from rabbit liver. J. Biol. Chem. 258 (1983) 840-845
10. Choi S.-Y., Churchich J.E., Zaiden E., and Kwok F. Brain pyridoxine-5-phosphate oxidase. Modulation of its catalytic activity by reaction with pyridoxal 5-phosphate and analogs. J. Biol. Chem. 262 (1987) 12013-12017
11. Coimbra N.C., De Oliveira R., Freitas R.L., Ribeiro S.J., Borelli K.G., Pacagnella R.C., Moreira J.E., da Silva L.A., Melo L.L., Lunardi L.O., and Brandao M.L. Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia. Exp. Neurol. 197 (2006) 93-112
12. Dakshinamurti K., Sharma S.K., and Geiger J.D. Neuroprotective actions of pyridoxine. Biochim. Biophys. Acta 1647 (2003) 225-229
13. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
14. Esclapez M., and Houser C.R. Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J. Comp. Neurol. 412 (1999) 488-505
15. Esclapez M., Tillakaratne N.J., Kaufman D.L., Tobin A.J., and Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14 (1994) 1834-1855
16. Feldblum S., Erlander M.G., and Tobin A.J. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34 (1993) 689-706
17. 6 vitamers in Escherichia coli as determined by enzymatic assay. Anal. Biochem. 298 (2001) 314-321
18. Gajkowska B., Gadamski R., and Mossakowski M. Immuno-electron microscopic demonstration of GABA and glutamate synapses in Mongolian gerbils hippocampus after ischemia. Folia Neuropathol. 33 (1995) 5-19
19. Gan P., Cheng J.S., Ng Y.K., and Ling E.A. Role of GABA in electro-acupuncture therapy on cerebral ischemia induced by occlusion of the middle cerebral artery in rats. Neurosci. Lett. 383 (2005) 317-321
20. 6 and its related compounds on survival of cultured brain neurons. Neurosci. Res. 24 (1995) 61-65
21. Gerstein M., Huleihel M., Mane R., Stilman M., Kashtuzki I., Hallak M., and Golan H. Remodeling of hippocampal GABAergic system in adult offspring after maternal hypoxia and magnesium sulfate load: immunohistochemical study. Exp. Neurol. 196 (2005) 18-29
22. Heldt S.A., Green A., and Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29 (2004) 1610-1619
23. Huang J., Agus D.B., Winfree C.J., Kiss S., Mack W.J., McTaggart R.A., Choudhri T.F., Kim L.J., Mocco J., Pinsky D.J., Fox W.D., Israel R.J., Boyd T.A., Golde D.W., and Connolly Jr. E.S. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11720-11724
24. Hwang I.K., Yoo K.Y., Kim D.S., Eum W.S., Park J.K., Park J., Kwon O.S., Kang T.C., Choi S.Y., and Won M.H. Changes of pyridoxal kinase expression and activity in the gerbil hippocampus following transient forebrain ischemia. Neuroscience 128 (2004) 511-518
25. Hwang I.K., Yoo K.Y., Park J.K., Nam Y.S., Lee I.S., Kang J.H., Choi S.Y., Lee J.Y., Kang T.C., and Won M.H. Ischemia-related changes of adrenocorticotropic hormone immunoreactivity and its protective effect in the gerbil hippocampus after transient forebrain ischemia. Neuroscience 126 (2004) 871-877
26. Hwang I.K., Eum W.S., Yoo K.Y., Cho J.H., Kim D.W., Choi S.H., Kang T.C., Kwon O.S., Kang J.H., Choi S.Y., and Won M.H. Copper chaperone for Cu,Zn-SOD supplement potentiates the Cu,Zn-SOD function of neuroprotective effects against ischemic neuronal damage in the gerbil hippocampus. Free Radic. Biol. Med. 39 (2005) 392-402
27. Iwata O., Thornton J.S., Sellwood M.W., Iwata S., Sakata Y., Noone M.A., O'Brien F.E., Baimbridge A., De Vita E., Raivich G., Peebles D., Scaravilli F., Cady E.B., Ordidge R., Wyatt J.S., and Robertson N.J. Depth of delayed cooling alters neuroprotection pattern after hypoxia-ischemia. Ann. Neurol. 58 (2005) 75-87
28. Jabaudon D., Scanziani M., Gahwiler B.H., and Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5610-5615
29. Jang Y.M., Kim D.W., Kang T.C., Won M.H., Baek N.I., Moon B.J., Choi S.Y., and Kwon O.S. Human pyridoxal phosphatase. Molecular cloning, functional expression, and tissue distribution. J. Biol. Chem. 278 (2003) 50040-50046
30. Jinno S., and Kosaka T. Immunocytochemical characterization of hippocamposeptal projecting GABAergic nonprincipal neurons in the mouse brain: a retrograde labeling study. Brain Res. 945 (2002) 219-231
31. Johansen F.F., Lin C.T., Schousboe A., and Wu J.Y. Immunocytochemical investigation of l-glutamic acid decarboxylase in the rat hippocampal formation: the influence of transient cerebral ischemia. J. Comp. Neurol. 281 (1989) 40-53
32. Kandzari D.E., Dery J.P., Armstrong P.W., Douglas D.A., Zettler M.E., Hidinger G.K., Friesen A.D., and Harrington R.A. MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury. Expert Opin. Investig. Drugs 14 (2005) 1435-1442
33. Kang T.C., Park S.K., Bahn J.H., Chang J.S., Koh W.S., Jo S.M., Cho S.W., Choi S.Y., and Won M.H. Elevation of the gamma-aminobutyric acid transaminase expression in the gerbil CA1 area after ischemia-reperfusion damage. Neurosci. Lett. 294 (2000) 33-36
34. Kang T.C., Park S.K., Hwang I.K., An S.J., Bahn J.H., Kim A.Y., Choi S.Y., Kwon O.S., Baek N.I., Lee H.Y., and Won M.H. Chronological changes in pyridoxine-5′-phosphate oxidase immunoreactivity in the seizure-sensitive gerbil hippocampus. J. Neurosci. Res. 68 (2002) 785-791
35. Kang T.C., Park S.K., Hwang I.K., An S.J., Choi S.Y., Cho S.W., and Won M.H. Spatial and temporal alterations in the GABA shunt in the gerbil hippocampus following transient ischemia. Brain Res. 944 (2002) 10-18
36. 6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 34 (2003) e51-e54
37. 6 status after ischemic stroke. Stroke 35 (2004) 12-15
38. Kelly S., Zhao H., Hua Sun G., Cheng D., Qiao Y., Luo J., Martin K., Steinberg G.K., Harrison S.D., and Yenari M.A. Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp. Neurol. 188 (2004) 378-386
39. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239 (1982) 57-69
40. Li X., Blizzard K.K., Zeng Z., DeVries A.C., Hurn P.D., and McCullough L.D. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp. Neurol. 187 (2004) 94-104
41. 6 Metabolism and Role in Growth (1980), Food and Nutrition Press, Westport, CT
42. Lust W.D., Assaf H.M., Ricci A.J., Ratcheson R.A., and Sternau L.L. A role for gamma-aminobutyric acid (GABA) in the evolution of delayed neuronal death following ischemia. Metab. Brain Dis. 3 (1988) 287-292
43. Martin D.L., Liu H., Martin S.B., and Wu S.J. Structural features and regulatory properties of the brain glutamate decarboxylases. Neurochem. Int. 37 (2000) 111-119
44. Meno J.R., Higashi H., Cambray A.J., Zhou J., D'Ambrosio R., and Winn H.R. Hippocampal injury and neurobehavioral deficits are improved by PD 81,723 following hyperglycemic cerebral ischemia. Exp. Neurol. 183 (2003) 188-196
45. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
46. Petito C.K., and Pulsinelli W.A. Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes. J. Cereb. Blood Flow Metab. 4 (1984) 194-205
47. Pham V., Zhang W., Chen V., Whitney T., Yao J., Froese D., Friesen A.D., Diakur J.M., and Haque W. Design and synthesis of novel pyridoxine 5′-phosphonates as potential antiischemic agents. J. Med. Chem. 46 (2003) 3680-3687
48. Rothman S.M., and Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19 (1986) 105-111
49. Sims N.R., and Anderson M.F. Mitochondrial contributions to tissue damage in stroke. Neurochem. Int. 40 (2002) 511-526
50. Tillakaratne N.J., Medina-Kauwe L., and Gibson K.M. γ-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp. Biochem. Physiol., A Physiol. 112 (1995) 247-263
51. 6 protects primate retinal neurons from ischemic injury. Brain Res. 940 (2002) 36-43
52. Wang C.X., Yang T., Noor R., and Shuaib A. Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats. J. Neurosurg. 103 (2005) 165-169
53. Yamashima T., Zhao L., Wang X.D., Tsukada T., and Tonchev A.B. Neuroprotective effects of pyridoxal ephosphate and pyridoxal against ischemia in monkeys. Nutr. Neurosci. 4 (2001) 389-397
54. Zhao G., and Winkler M.E. Kinetic limitation and cellular amount of pyridoxine (pyridoxamine) 5′-phosphate oxidase of Escherichia coli K-12. J. Bacteriol. 177 (1995) 883-891